Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA)

This publication has 14 references indexed in Scilit:

• Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis
  Journal of the American College of Cardiology, 1987
• Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator.
  Journal of Clinical Investigation, 1987
• Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
  Circulation, 1986
• Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis
  Journal of the American College of Cardiology, 1986
• Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.
  Circulation, 1985
• A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin
  Molecular Immunology, 1983
• [29] Human plasminogen
  Published by Elsevier ,1981
• The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X
  Analytical Biochemistry, 1980
• Radioimmunoassay of fibrinopeptide A - clinical applications
  Thrombosis Research, 1976
• Measurement of Fibrinopeptide A in Human Blood
  Journal of Clinical Investigation, 1974